Clinical Trial

Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to construct a risk tool available for screening young adults and adolescents at high risk of drug misuse and provides a chance for early intervention to young adults and adolescents at high risk of drug misuse, which prevent the onset and development of drug addiction in the future.The main question it aims to answer is: 1. Explore the occurrence and influencing factors of new psychoactive substance misuse among young adults and adolescents; 2. Construct a risk prediction model for new psychoactive substance misuse among young adults and adolescents and conduct internal verification of the model; 3. Based on the results of the prediction model, select the optimal model to initially form a concise scale "Screening Tool for the Risk of New Psychoactive Substance Misuse among Young Adults and Adolescents"; 4. Conduct external verification of the tool, and revise and improve the screening tool, form the final version of the screening tool, and verify the application performance of the screening tool.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-27; most recent amendment 2024-12-13.
Trial Details
NCT Number NCT06714578
Lead Sponsor Wei XIA, PhD
Conditions Drug Misuse, Addiction
Enrollment 1,035 participants
Start Date 2024-12-15
Primary Completion 2025-08-15 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-18